Image-based brachytherapy for cervical cancer

World Journal of Clinical Oncology

Volumn 5, Issue 5, 2014, Pages 921-930

  Vargo, John A ^a   Beriwal, Sushil ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

3D planning; Brachytherapy; Cervical cancer; Groupe Europeen de Curietherapie European Society for Therapeutic Radiology and Oncology Working Group guidelines; Imagebased brachytherapy; Magnetic resonance imaging based brachytherapy

Indexed keywords

EID: 84913608208     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v5.i5.921     Document Type: Article

References (59)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078]
3. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350: 535-540 [PMID: 9284774]
4. Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991; 20: 667-676 [PMID: 2004942]
5. Montana GS, Hanlon AL, Brickner TJ, Owen JB, Hanks GE, Ling CC, Komaki R, Marcial VA, Thomas GM, Lanciano R. Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. Int J Radiat Oncol Biol Phys 1995; 32: 1481-1486 [PMID: 7635793]
6. ICRU report no 38. Dose and volume specification for reporting intracavitary therapy in gynecology. Bethesda MD: International Commission on Radiation Units and Measurements, 1985
7. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48: 201-211 [PMID: 10924990]
8. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994; 29: 9-16 [PMID: 8175451]
9. Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999; 43: 763-775 [PMID: 10098431]
10. Katz A, Eifel PJ. Quantification of intracavitary brachytherapy parameters and correlation with outcome in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 48: 1417-1425 [PMID: 11121642]
11. Kim RY, Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms. Brachytherapy 2003; 2: 200-206 [PMID: 15062127]
12. Zwahlen D, Jezioranski K, Chan P, Haider MA, Cho YB, Yeung I, Levin W, Manchul L, Fyles A, Milosevic M. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys 2009; 74: 1157-1164 [PMID: 19101097]
13. Kim H, Beriwal S, Houser C, Huq MS. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy? Med Dosim 2011; 36: 166-170 [PMID: 20488690 DOI: 10.1016/j.meddos.2010.02.009]
14. Kim RY, Shen S, Duan J. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel. Brachytherapy 2007; 6: 187-194 [PMID: 17606413]
15. Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Brachytherapy 2008; 7: 336-342 [PMID: 18782683 DOI: 10.1016/j.brachy.2008.05.005]
16. Shin KH, Kim TH, Cho JK, Kim JY, Park SY, Park SY, Kim DY, Chie EK, Pyo HR, Cho KH. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters. Int J Radiat Oncol Biol Phys 2006; 64: 197-204 [PMID: 16169676]
17. Onal C, Arslan G, Topkan E, Pehlivan B, Yavuz M, Oymak E, Yavuz A. Comparison of conventional and CTbased planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res 2009; 28: 95 [PMID: 19570212 DOI: 10.1186/1756-9966-28-95]
18. Datta NR, Srivastava A, Maria Das KJ, Gupta A, Rastogi N. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer. Brachytherapy 2006; 5: 223-229 [PMID: 17118314]
19. Ling CC, Schell MC, Working KR, Jentzsch K, Harisiadis L, Carabell S, Rogers CC. CT-assisted assessment of bladder and rectum dose in gynecological implants. Int J Radiat Oncol Biol Phys 1987; 13: 1577-1582 [PMID: 3624031]
20. Schoeppel SL, LaVigne ML, Martel MK, McShan DL, Fraass BA, Roberts JA. Three-dimensional treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 1994; 28: 277-283 [PMID: 8270452]
21. Stuecklschweiger GF, Arian-Schad KS, Poier E, Poschauko J, Hackl A. Bladder and rectal dose of gynecologic highdose-rate implants: comparison of orthogonal radiographic measurements with in vivo and CT-assisted measurements. Radiology 1991; 181: 889-894 [PMID: 1947116]
22. Kapp KS, Stuecklschweiger GF, Kapp DS, Hackl AG. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CTassisted techniques. Radiother Oncol 1992; 24: 137-146 [PMID: 1410567]
23. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005; 62: 131-137 [PMID: 15850913]
24. Koom WS, Sohn DK, Kim JY, Kim JW, Shin KH, Yoon SM, Kim DY, Yoon M, Shin D, Park SY, Cho KH. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 2007; 68: 1446-1454 [PMID: 17482766]
25. Georg P, Kirisits C, Goldner G, Dörr W, Hammer J, Pötzi R, Berger D, Dimopoulos J, Georg D, Pötter R. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 2009; 91: 173-180 [PMID: 19243846 DOI: 10.1016/j.radonc.2009.01.006]
26. Georg P, Pötter R, Georg D, Lang S, Dimopoulos JC, Sturdza AE, Berger D, Kirisits C, Dörr W. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Int J Radiat Oncol Biol Phys 2012; 82: 653-657 [PMID: 21345618 DOI: 10.1016/j.ijrobp.2010.12.029]
27. Barnes EA, Thomas G, Ackerman I, Barbera L, Letourneau D, Lam K, Makhani N, Sankreacha R. Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix. Int J Gynecol Cancer 2007; 17: 821-826 [PMID: 17359295]
28. Al-Booz H, Boiangiu I, Appleby H, French C, Coomber H, Humphery P, Cornes P. Sigmoid colon is an unexpected organ at risk in brachytherapy for cervix cancer. J Egypt Natl Canc Inst 2006; 18: 156-160 [PMID: 17496941]
29. Dimopoulos JC, Kirisits C, Petric P, Georg P, Lang S, Berger D, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006; 66: 83-90 [PMID: 16839702]
30. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007; 83: 148-155 [PMID: 17531904]
31. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, Dumas I, Hellebust TP, Kirisits C, Lang S, Muschitz S, Nevinson J, Nulens A, Petrow P, Wachter-Gerstner N. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-245 [PMID: 15763303]
32. Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, Dumas I, Erickson B, Lang S, Nulens A, Petrow P, Rownd J, Kirisits C. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77 [PMID: 16403584]
33. Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys 2004; 60: 1160-1172 [PMID: 15519788]
34. Dimopoulos JC, Schard G, Berger D, Lang S, Goldner G, Helbich T, Pötter R. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys 2006; 64: 1380-1388 [PMID: 16580496]
35. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRIbased treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005; 62: 901-911 [PMID: 15936576]
36. Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006; 65: 624-630 [PMID: 16690444]
37. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008; 71: 756-764 [PMID: 18191335 DOI: 10.1016/j.ijrobp.2007.10.032]
38. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008; 88: 217-226 [PMID: 18037524]
39. Pötter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, Georg D, Schmid MP, Reinthaller A, Sturdza A, Kirisits C. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100: 116-123 [PMID: 21821305 DOI: 10.1016/j.radonc.2011.07.012]
40. Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Pötter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007; 68: 491-498 [PMID: 17331668]
41. Tan LT, Coles CE, Hart C, Tait E. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 2009; 21: 175-182 [PMID: 19101130 DOI: 10.1016/j.clon.2008.12.001]
42. Beriwal S, Kim H, Coon D, Mogus R, Heron DE, Li X, Huq MS. Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical cancer brachytherapy. Clin Oncol (R Coll Radiol) 2009; 21: 483-487 [PMID: 19423307 DOI: 10.1016/j.clon.2009.03.007]
43. Beriwal S, Kannan N, Kim H, Houser C, Mogus R, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards RP, Krivak TC. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results. Clin Oncol (R Coll Radiol) 2011; 23: 685-690 [PMID: 21908180 DOI: 10.1016/j.clon.2011.08.007]
44. Nesvacil N, Pötter R, Sturdza A, Hegazy N, Federico M, Kirisits C. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction. Radiother Oncol 2013; 107: 75-81 [PMID: 23068712 DOI: 10.1016/j.radonc.2012.09.005]
45. Mahantshetty U, Khanna N, Swamidas J, Engineer R, Thakur MH, Merchant NH, Deshpande DD, Shrivastava S. Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix. Radiother Oncol 2012; 102: 130-134 [PMID: 21885140 DOI: 10.1016/j.radonc.2011.08.001]
46. Van Dyk S, Narayan K, Fisher R, Bernshaw D. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys 2009; 75: 64-70 [PMID: 19250767 DOI: 10.1016/j.ijrobp.2008.10.057]
47. Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, Castelain B, Thomas L, Peiffert D. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol 2012; 103: 305-313 [PMID: 22633469 DOI: 10.1016/j.radonc.2012.04.007]
48. Gill BS, Kim H, Houser C, Hosseinzadeh K, Beriwal S. Clinical outcomes for 3D high-dose-rate intracavitary brachytherapy with MRI-based planning for the treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2013; 87: S73
49. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magné N. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRIbased low dose rate brachytherapy followed by surgery. Radiother Oncol 2009; 93: 316-321 [PMID: 19586673 DOI: 10.1016/j.radonc.2009.05.004]
50. Narayan K, van Dyk S, Bernshaw D, Rajasooriyar C, Kondalsamy-Chennakesavan S. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival. Int J Radiat Oncol Biol Phys 2009; 74: 1529-1535 [PMID: 19473780 DOI: 10.1016/j.ijrobp.2008.10.085]
51. Kang HC, Shin KH, Park SY, Kim JY. 3D CT-based highdose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control. Radiother Oncol 2010; 97: 507-513 [PMID: 21074881 DOI: 10.1016/j.radonc.2010.10.002]
52. Dimopoulos JC, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, Dörr W, Pötter R. Dose-volume histogram parameters and local tumor control in magnetic resonance imageguided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009; 75: 56-63 [PMID: 19289267 DOI: 10.1016/j.ijrobp.2008.10.033]
53. Viswanathan AN, Thomadsen B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy 2012; 11: 33-46 [PMID: 22265436 DOI: 10.1016/j.brachy.2011.07.003]
54. Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 2012; 11: 47-52 [PMID: 22265437 DOI: 10.1016/j.brachy.2011.07.002]
55. Lee LJ, Das IJ, Higgins SA, Jhingran A, Small W, Thomadsen B, Viswanathan AN, Wolfson A, Eifel P. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy 2012; 11: 53-57 [PMID: 22265438 DOI: 10.1016/j.brachy.2011.07.001]
56. Dolezel M, Odrazka K, Vanasek J, Kohlova T, Kroulik T, Kudelka K, Spitzer D, Mrklovsky M, Tichy M, Zizka J, Jalcova L. MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy. Br J Radiol 2011; 84: 850-856 [PMID: 21849368 DOI: 10.1259/bjr/75446993]
57. De Leeuw AA, Moerland MA, Nomden C, Tersteeg RH, Roesink JM, Jürgenliemk-Schulz IM. Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer. Radiother Oncol 2009; 93: 341-346 [PMID: 19515443 DOI: 10.1016/j.radonc.2009.05.003]
58. Tanderup K, Hellebust TP, Lang S, Granfeldt J, Pötter R, Lindegaard JC, Kirisits C. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 2008; 89: 156-163 [PMID: 18692265 DOI: 10.1016/j.radonc.2008.06.010]
59. Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K. Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. Radiother Oncol 2009; 91: 187-193 [PMID: 18977049 DOI: 10.1016/j.radonc.2008.09.002]